Boston Scientific

Rank: 16
2015 Rank12
Employees25,000
Revenue:$7,477,000,000
R&D Spend:$876,000,000
Fiscal year ending:12-31-15
Click here to see all 100

Boston Scientific Announces U.S. FDA Approval of Navigation-Enabled Ablation Catheters; Boston Scientific Receives U.S. FDA Approval For ImageReady MR-Conditional Pacing System; Boston Scientific Announces CE Mark For MRI Labeling Of Emblem S-ICD Systems

2015 Top 500 Solar Contractors Key Personnel: Michael Mahoney, President & CEO; Kevin Ballinger, SVP & President, Interventional Cardiology; Supratim Bose, EVP & President, APac, Middle East & Africa; Daniel Brennan, EVP & CFO; Wendy Carruthers, SVP, HR; Dr. Keith Dawkins, EVP & Global Chief Medical Officer; Joseph Fitzgerald, EVP & President, Rhythm Management; Edward Mackey, EVP, Operations; Jeff Mirviss, SVP & President, Peripheral Interventions; Maulik Nanavaty, SVP & President, Neuromodulation; Michael Phalen, EVP & President, Medsurg; David Pierce, SVP & President, Endoscopy; Karen Prange, SVP & President, Urology & Women’S Health; Timothy Pratt, EVP, Chief Administrative Officer, GC & Secretary; Brad Sorenson, SVP, Manufacturing & Supply Chain; Eric Thépaut, SVP & President, Europe;

300 BOSTON SCIENTIFIC WAY
Marlborough, Massachusetts
1752
USA